Limiting the location of a putative human prostate cancer tumor suppressor gene at chromosome 13q14.3
Open Access
- 9 December 1999
- journal article
- research article
- Published by Springer Nature in Oncogene
- Vol. 18 (52), 7576-7583
- https://doi.org/10.1038/sj.onc.1203203
Abstract
We studied loss of heterozygosity (LOH) on human chromosome 13q in prostate cancer specimens to determine the location of a putative tumor suppressor gene (TSG) and to correlate these losses with the clinicopathological stage of the disease. Overall 13 (21%) of 61 specimens analysed had an allele loss on the long arm of chromosome 13. The most frequent (37%) LOH among the informative cases with allele losses was detected at the D13S284 locus on chromosome 13q14.3. A portion of the DNA segment that spans this locus and is flanked by the microsatellite loci D13S153 and D13S163 was lost in 85% of the specimens with allele losses and was designated as a LOH cluster region (LCR). The LCR spans more than 6 Mbp of DNA. The results suggest that a TSG relevant for the development of prostate cancer is located telomeric to the RB locus. There was a significant correlation (P=0.0024) between chromosome 13q LOH and advanced metastatic disease, suggesting that loss of 13q14.3 region is associated with prostate cancer progression. However, further research must be conducted to establish the identity and function of this putative TSG.Keywords
This publication has 26 references indexed in Scilit:
- Cancer statistics, 1999CA: A Cancer Journal for Clinicians, 1999
- Identification of two distinct deleted regions on chromosome 13 in prostate cancerOncogene, 1998
- p53 Protein and Gene Alterations in Pathological Stage C Prostate CarcinomaJournal of Urology, 1997
- Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancersNature Genetics, 1997
- PTEN , a Putative Protein Tyrosine Phosphatase Gene Mutated in Human Brain, Breast, and Prostate CancerScience, 1997
- Loss of heterozygosity studies at the retinoblastoma and breast cancer susceptibility (BRCA2) loci in pituitary, parathyroid, pancreatic and carcinoid tumoursClinical Endocrinology, 1996
- The complete BRCA2 gene and mutations in chromosome 13q-linked kindredsNature Genetics, 1996
- Allelic loss of the retinoblastoma gene in primary human prostatic adenocarcinomasThe Prostate, 1995
- Analysis of retinoblastoma (RB) gene deletion in human prostatic carcinomasThe Prostate, 1992
- Allelotyping of human prostatic adenocarcinomaGenomics, 1991